CVS Health Corporation (NYSE:CVS – Get Free Report) announced a quarterly dividend on Tuesday, January 6th. Stockholders of record on Thursday, January 22nd will be paid a dividend of 0.665 per share by the pharmacy operator on Monday, February 2nd. This represents a c) dividend on an annualized basis and a dividend yield of 3.3%. The ex-dividend date of this dividend is Thursday, January 22nd.
CVS Health has increased its dividend payment by an average of 0.1%per year over the last three years and has raised its dividend annually for the last 4 consecutive years. CVS Health has a payout ratio of 37.7% indicating that its dividend is sufficiently covered by earnings. Analysts expect CVS Health to earn $6.77 per share next year, which means the company should continue to be able to cover its $2.66 annual dividend with an expected future payout ratio of 39.3%.
CVS Health Trading Up 0.4%
Shares of CVS traded up $0.29 during mid-day trading on Tuesday, hitting $80.71. 10,636,343 shares of the company’s stock traded hands, compared to its average volume of 8,051,814. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. The firm has a market capitalization of $102.45 billion, a P/E ratio of 212.39, a PEG ratio of 0.74 and a beta of 0.48. The business’s 50-day moving average price is $78.63 and its 200-day moving average price is $73.55. CVS Health has a 1 year low of $44.92 and a 1 year high of $85.15.
Analyst Ratings Changes
A number of equities analysts recently issued reports on CVS shares. Morgan Stanley increased their price target on shares of CVS Health from $89.00 to $93.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 10th. Argus upped their target price on CVS Health from $80.00 to $91.00 and gave the stock a “buy” rating in a report on Tuesday, November 4th. Wells Fargo & Company lowered their target price on CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a research note on Thursday, November 13th. TD Cowen lifted their price target on CVS Health from $100.00 to $105.00 and gave the company a “buy” rating in a research report on Wednesday, December 10th. Finally, Cantor Fitzgerald reiterated an “overweight” rating on shares of CVS Health in a report on Wednesday, December 10th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $94.86.
Read Our Latest Research Report on CVS
CVS Health Company Profile
CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.
Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.
Featured Articles
- Five stocks we like better than CVS Health
- A month before the crash
- How a Family Trust May Be Able To Help Preserve Your Wealth
- The Discovery That Put Idaho’s Copper Belt on the Map
- The $100 Trillion AI Story No One Is Telling You
- S&P 8000
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.
